These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18477990)

  • 1. Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
    Coyne DW
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):364-5. PubMed ID: 18477990
    [No Abstract]   [Full Text] [Related]  

  • 2. Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
    de Francisco AL; Piñera C; Palomar R
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):366-7. PubMed ID: 18506170
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism.
    Dorsch O
    Nephrol Dial Transplant; 2007 Feb; 22(2):637-40. PubMed ID: 17095580
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of cinacalcet in treating secondary hyperparathyroidism.
    Brommage D; Gallgano C
    Nephrol Nurs J; 2005; 32(2):229-31. PubMed ID: 15889812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.
    Drüeke TB
    Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism?
    Fukagawa M
    Nat Clin Pract Nephrol; 2006 May; 2(5):248-9. PubMed ID: 16932435
    [No Abstract]   [Full Text] [Related]  

  • 7. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of cinacalcet in addition to standard of care in the UK.
    Ray JA; Valentine WJ; Palmer AJ
    Nephrol Dial Transplant; 2007 Nov; 22(11):3355-7; author reply 3357-8. PubMed ID: 17785347
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
    Kalantar-Zadeh K; Kovesdy CP
    Am J Kidney Dis; 2009 Feb; 53(2):183-8. PubMed ID: 19166796
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinacalcet improves control of secondary hyperparathyroidism in peritoneal dialysis: a multicenter study.
    Portolés J; López-Sánchez P; Bajo MA; Castellano I; del Peso G; Rodríguez JR; Ribera M; Ortigosa A; Selgas R
    Perit Dial Int; 2012; 32(2):208-11. PubMed ID: 22383721
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
    Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA
    Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism.
    Jean G; Chazot C; Charra B
    Nephrol Dial Transplant; 2007 Jul; 22(7):2102-3. PubMed ID: 17395648
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?
    Cannata-Andía JB; Fernández-Martín JL
    Nat Rev Nephrol; 2009 Jun; 5(6):307-8. PubMed ID: 19474823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to treatment of secondary hyperparathyroidism.
    Locatelli F; Limardo M; Pontoriero G
    Curr Opin Investig Drugs; 2008 Apr; 9(4):363-70. PubMed ID: 18393103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism.
    Koizumi M; Komaba H; Nakanishi S; Fujimori A; Fukagawa M
    Nephrol Dial Transplant; 2012 Feb; 27(2):784-90. PubMed ID: 21730210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When evidence does not correspond to cost-effectiveness].
    Vernaglione L
    G Ital Nefrol; 2007; 24(6):493. PubMed ID: 18278749
    [No Abstract]   [Full Text] [Related]  

  • 20. Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?
    Kakuta T; Tanaka R; Kanai G; Sawaya A; Hirukawa T; Sato A; Saito A
    Ther Apher Dial; 2009 Oct; 13 Suppl 1():S20-7. PubMed ID: 19765255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.